TRIM9 and TRIM26 Interact with UBQLN2 P497H to Modulate Its Proteasomal Degradation
ACS Chemical Biology · 20.02.2026 · 21 (2) · 230-234
DOI: 10.1021/acschembio.5c00911 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 26.01.2026. Verfasst von Xingyuan Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Environmental Toxicology Graduate Program, University of California, Riverside, California 92521, United States. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Proteasome Endopeptidase Complex, Adaptor Proteins, Signal Transducing, Tripartite Motif Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Environmental Toxicology Graduate Program, University of California, Riverside, California 92521, United States.
- Department of Chemistry, University of California, Riverside, California 92521, United States.
ORCID-Profile: Xingyuan Chen, Yinsheng Wang
Förderung
- NIEHS NIH HHS
- National Institutes of Health
Zitieren
APA
Chen, X., Cao, Z., Liang, X., Zhao, T., & Wang, Y. (2026). TRIM9 and TRIM26 Interact with UBQLN2 P497H to Modulate Its Proteasomal Degradation. ACS Chemical Biology, 21(2), 230-234. https://doi.org/10.1021/acschembio.5c00911
Vancouver
Chen X, Cao Z, Liang X, Zhao T, Wang Y. TRIM9 and TRIM26 Interact with UBQLN2 P497H to Modulate Its Proteasomal Degradation. ACS Chemical Biology. 2026;21(2):230-234. doi:10.1021/acschembio.5c00911
BibTeX
@article{Chen2026,
author = {Chen, Xingyuan and Cao, Zhongwen and Liang, Xiaochen and Zhao, Ting and Wang, Yinsheng},
title = {TRIM9 and TRIM26 Interact with UBQLN2 P497H to Modulate Its Proteasomal Degradation},
journal = {ACS Chemical Biology},
year = {2026},
volume = {21},
number = {2},
pages = {230--234},
doi = {10.1021/acschembio.5c00911}
}
EUVIMED